Filing Flows

Filing Flows › Companies › Claritev › Cash flow

Claritev cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow$54.6M in Q2 2026 · −$17.9M over twelve months

Operating cash flow$92.7M
Capital spending−$38.1M
Free cash flow+$54.6M
Cash conversion cycle-30 days

Analysis

In Q2 2026, Claritev generated $92.7M of operating cash flow and spent $38.1M on capital projects, leaving free cash flow of $54.6M. That is $18.0M more than in Q2 2025 ($36.6M).

Over the twelve months to Jun 30, 2026, operating cash flow was $133M; the largest uses were capital spending ($151M), other financing ($14.7M), net borrowing (+) / repaid (−) ($10.0M); besides operations, cash came from other investing ($8.6M), shares issued ($2.0M); the cash balance fell by $39.6M.

Operating cash flow was $92.7M against net income of −$59.2M. The largest differences: depreciation & amortization +$111M, accrued liabilities +$49.8M, deferred taxes −$28.6M.

Its cash conversion cycle was -30 days (receivables 48 + inventory 0 − payables 78): suppliers fund its working capital.

Free cash flow

Claritev: free cash flow by quarterClaritev: free cash flow by quarter$41.1MQ3 2024−$63.8MQ4 2024−$68.9MQ1 2025$36.6MQ2 2025−$16.3MQ3 2025$36.4MQ4 2025−$92.5MQ1 2026$54.6MQ2 2026
Operating cash flow less capital spending.
Claritev: operating cash flow against capital spendingClaritev: operating cash flow against capital spendingOperating cash flowCapital spending$72.8M$31.7MQ3 2024−$33.4M$30.4MQ4 2024−$30.1M$38.9MQ1 2025$61.2M$24.6MQ2 2025$19.9M$36.2MQ3 2025$66.3M$29.9MQ4 2025−$45.8M$46.8MQ1 2026$92.7M$38.1MQ2 2026
Latest (Q2 2026): Operating cash flow $92.7M, Capital spending $38.1M.

Capital allocation, year by year

Claritev: where the cash came from (up) and went (down), by fiscal yearClaritev: where the cash came from (up) and went (down), by fiscal yearOperating cash flowShares issuedCapital spendingAcquisitionsBuybacksFY2021: Operating cash flow $405MFY2021: Capital spending −$84.6MFY2021: Buybacks −$100M$405MFY2021FY2022: Operating cash flow $372MFY2022: Capital spending −$89.7M$372MFY2022FY2023: Operating cash flow $172MFY2023: Shares issued $508KFY2023: Capital spending −$109MFY2023: Buybacks −$15.2M$172MFY2023FY2024: Operating cash flow $108MFY2024: Shares issued $1.1MFY2024: Capital spending −$118MFY2024: Buybacks −$10.4M$109MFY2024FY2025: Operating cash flow $117MFY2025: Shares issued $1.7MFY2025: Capital spending −$130MFY2025: Acquisitions −$4.8M$119MFY2025
Over these 5 years operating cash flow totalled $1.2B; the largest uses were capital spending ($531M) and buybacks ($126M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$14.4M
Debt$4.6B
Net debt$4.6B
Due within a year$14.7M

Claritev's operations bring cash in ($133M over twelve months), and it spends more than that on capital projects: a gap of $17.9M funded from its $14.4M of cash and investments and from borrowing ($4.6B of debt, $14.7M due within a year). That is a choice to invest, not a cash runway running down.

Claritev: debt maturities by year (FY2025)Claritev: debt maturities by year (FY2025)$14.7MYear 1$15.1MYear 2$25.8MYear 3$14.7MYear 4$2.8BYear 5$1.8BAfter year 5
Principal due in each year as disclosed in the annual report, against $14.4M of cash and investments now.

Where the cash came from and went

Claritev: sources (+) and uses (−) of cash, Q2 2026Claritev: sources (+) and uses (−) of cash, Q2 2026Operating cash flow$92.7MNet borrowing (+) / repaid (−)−$58.7MCapital spending−$38.1MCash drawn (+) / kept (−)$7.1MOther financing−$3.5MShares issued$537KTaxes on employees’ shares−$4K
Claritev: sources (+) and uses (−) of cash, TTM to Q2 2026Claritev: sources (+) and uses (−) of cash, TTM to Q2 2026Capital spending−$151MOperating cash flow$133MCash drawn (+) / kept (−)$39.6MOther financing−$14.7MNet borrowing (+) / repaid (−)−$10.0MOther investing$8.6MTaxes on employees’ shares−$4.1MBuybacks−$3.5MShares issued$2.0M

From profit to cash

Claritev: net income to operating cash flow, Q2 2026Claritev: net income to operating cash flow, Q2 2026Net income−$59.2MDepreciation & amortization$111MStock-based pay$7.4MDeferred taxes−$28.6MGains on disposals$57KReceivables$5.3MPayables−$2.5MAccrued liabilities$49.8MPrepaid and other assets−$6.1MOperating cash flow$92.7M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q2 202648—78-30
Q1 202649—78-29
Q4 202548—65-18
Q3 202547—61-14
Q2 202541—58-17
Q1 202536—90-54
Q4 202434—88-54
Q3 202433—34-1

Every quarter

QuarterOperating cash flowCapital spendingNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q2 2026$92.7M−$38.1M−$58.7M$537K$7.1M$54.6M
Q1 2026−$45.8M−$46.8M$101M$464K−$6.4M−$92.5M
Q4 2025$66.3M−$29.9M−$55.0M$345K$22.3M$36.4M
Q3 2025$19.9M−$36.2M−$13.7M$648K$16.6M−$16.3M
Q2 2025$61.2M−$24.6M−$3.7M$448K−$33.4M$36.6M
Q1 2025−$30.1M−$38.9M$80.0M$301K−$4.2M−$68.9M
Q4 2024−$33.4M−$30.4M—$212K$67.5M−$63.8M
Q3 2024$72.8M−$31.7M−$3.3M$170K−$38.0M$41.1M

Claritev: income statement and cash flow

Claritev, Q2 2026: revenue $257M (+7% year over year), operating margin 9.1%. The chart follows the revenue to costs, profit and cash.

Claritev: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.